Hetero Biopharma @ Kenya Renal Association (KRA).
In continuation to the successful launch of Derise (Darbepoetin Alfa) in Kenya, Hetero Biopharma recently participated in Kenya Renal Association (KRA) conference, which is recognized to be a major annual knowledge platform in East Africa. This conference was organized for several leading nephrologists from east African countries namely Kenya, Uganda, Tanzania etc. The conference was scheduled from 27th – 30th Sept 2017. During this conference, Dr Ravindra Prabhu, Professor & Head of Dept. – Nephrology, Manipal Hospitals – India addressed the audience as a Key Opinion Leader (KOL) on behalf of Hetero Biopharma. He presented a session on ‘Management of Anaemia in CKD’ as well as highlighting the importance of DERISE (Darbepoetin Alfa) in the management of Anaemia associated with CKD & IRBIS (Irbesartan) in the management of Hypertension.
Dr. Praveen Shetty (AGM, Global Clinical Strategy & Medico Marketing) presented insights on Darbepoetin Alfa and also emphasized on the overall vision of Hetero Biopharma. The session ended with vote of thanks by Mr. Manish Soni (Country Manager- Kenya). Besides the session, Mr.Phanindranath (GM International Marketing) also showcased our product portfolio at the conference through our Hetero booth.